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Calpain-dependent disruption of 
nucleo-cytoplasmic transport in 
ALS motor neurons
Takenari Yamashita1, Hitoshi Aizawa2, Sayaka Teramoto1, Megumi Akamatsu1 & Shin Kwak1,3
Nuclear dysfunction in motor neurons has been hypothesized to be a principal cause of amyotrophic 
lateral sclerosis (ALS) pathogenesis. Here, we investigated the mechanism by which the nuclear pore 
complex (NPC) is disrupted in dying motor neurons in a mechanistic ALS mouse model (adenosine 
deaminase acting on RNA 2 (ADAR2) conditional knockout (AR2) mice) and in ALS patients. We showed 
that nucleoporins (Nups) that constituted the NPC were cleaved by activated calpain via a Ca2+-
permeable AMPA receptor-mediated mechanism in dying motor neurons lacking ADAR2 expression in 
AR2 mice. In these neurons, nucleo-cytoplasmic transport was disrupted, and the level of the transcript 
elongation enzyme RNA polymerase II phosphorylated at Ser2 was significantly decreased. Analogous 
changes were observed in motor neurons lacking ADAR2 immunoreactivity in sporadic ALS patients. 
Therefore, calpain-dependent NPC disruption may participate in ALS pathogenesis, and inhibiting Ca2+-
mediated cell death signals may be a therapeutic strategy for ALS.
Amyotrophic lateral sclerosis (ALS) is the most common adult-onset motor neuron disease of unknown etiology. 
It has long been known that both nuclear volume and RNA contents of motor neurons are decreased in ALS 
patients compared to healthy control subjects1. Recent findings of ALS-related genes encoding RNA-binding 
proteins (RBPs) such as TDP-43 and FUS and of a reduction or loss of these RBPs from the nuclei of anterior horn 
cells (AHCs) in ALS patients suggest a role of RNA dysregulation in ALS pathogenesis2–4. RNAs and RBPs are 
transported between the nucleus and the cytoplasm, and the nuclear pore complex (NPC) functions as a gateway 
for nucleo-cytoplasmic transport of these molecules5,6. Disruption of nucleo-cytoplasmic transport or the dys-
function of the NPC is a predicted mechanism underlying cell death7–10; and its potential role in ALS pathogenesis 
has also been suspected. Indeed, the gene encoding the GLE1 protein, a nucleoporin (Nup) that is a constituent of 
the NPC, has been associated with ALS11, and morphological changes in the nuclear membrane upon disruption 
of Nups have been observed in motor neurons of patients with sporadic ALS or with SOD1-associated ALS12,13. 
Moreover, nucleo-cytoplasmic transport through the NPC was found to be disrupted in cultured cells and in 
animals expressing the ALS-associated C9orf72 gene harboring an expanded GGGGCC (G4C2) hexanucleotide 
repeat sequence14–16. However, the manner in which NPC is disrupted in ALS motor neurons remains unclear.
Adenosine deaminase acting on RNA (ADAR)2 is a member of the ADAR family, which catalyzes the 
adenosine-to-inosine (A-to-I) conversion in pre-mRNA. Progressive down-regulation of ADAR2 with resultant 
failure of the A-to-I conversion at the glutamine/arginine (Q/R) site of GluA2, the Ca2+-regulating subunit of 
AMPA receptors, has been demonstrated in motor neurons of most patients with sporadic ALS17–19. Furthermore, 
conditional ADAR2 knockout mice (AR2 mice) displayed the ALS phenotype resulting from progressive degen-
eration of motor neurons, and also exhibited TDP-43 mislocalization that resembled TDP-43 pathology20,21, the 
most reliable pathological hallmark of ALS. This behaviorally and pathologically ALS-like phenotype of AR2 mice 
results from excess influx of Ca2+ through AMPA receptor complexes containing Q/R site-unedited GluA2 subu-
nits20,21; continuous Ca2+ influx through these abnormal AMPA receptors activates the Ca2+-dependent cysteine 
protease calpain, which cleaves TDP-43 into aggregation-prone fragments that serve as seeds for TDP-43 pathol-
ogy20–22. The above evidence indicates that the ADAR2-deficient motor neurons in AR2 mice mimic the pathoge-
netic mechanism of sporadic ALS. Notably, the motor neurons of AR2 mice possess abnormal vacuoles during the 
course of death, and these nuclear vacuoles disappear when Ca2+ influx through AMPA receptors is normalized23. 
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These pieces of evidence suggest the involvement of Ca2+-dependent dysregulation of nucleo-cytoplasmic trans-
port in the slow death of motor neurons in AR2 mice and ALS patients. In this study, we investigated how expres-
sion of Ca2+-permeable AMPA receptors disrupts the nucleo-cytoplasmic transport machinery in AR2 mice and 
whether similar alterations are present in motor neurons of ALS patients.
Results
Calpain-dependent degradation/denaturation of the NPC. First, we investigated whether the NPC 
was disrupted in ADAR2-deficient motor neurons in AR2 mice. Nup immunoreactivity was observed in the 
nuclear membrane and the perinuclear region of AHCs in wild-type mice (Fig. 1a and Supplementary Fig. S1) 
and ADAR2-positive AHCs in AR2 mice (Fig. 1b). In contrast, immunoreactivity for the Nup62, Nup88, and 
Nup153 proteins was absent from the perinuclear region but was detected as irregular granule-like fluorescence 
in the cytoplasm in ADAR2-deficient AHCs in AR2 mice (Fig. 1b). Because the Ca2+-dependent protease calpain 
is abnormally activated in AHCs lacking ADAR2 expression in AR2 mice21, we next examined whether calpain 
cleaves Nups. An in vitro calpain cleavage assay demonstrated that Flag-Nups were effectively cleaved by cal-
pain (Fig. 1c), which suggested that the lack of Nup immunoreactivity in ADAR2-deficient AHCs likely resulted 
from cleavage of Nups by activated calpain. To investigate calpain activity in ADAR2-deficient AHCs, we used 
polyclonal antibodies against the 136 kDa fragment of alpha-spectrin (136kf), a calpain-dependent fragment 
of alpha-spectrin that is a marker of prominent activation of calpain24. The ADAR2-deficient AHCs, but not 
ADAR2-positive AHCs, exhibited 136kf signals in the nuclei that were devoid of normal ring-like staining for 
Nup62 (Fig. 1d and Supplementary Fig. S2). Hence, to assess whether the lack of Nup62 in AR2 mouse AHCs 
was induced by the activation of calpain in response to an amplified Ca2+ influx through the AMPA receptors, we 
examined the changes in Nup62 and ADAR2 levels in AR2res (AR2/GluR-BR/R) mice, in which the endogenous 
GluA2 alleles were replaced with the GluR-BR allele, which encodes Q/R site-edited GluA220,25,26. The motor 
neurons in AR2res mice express basally Ca2+-impermeable AMPA receptor complexes containing edited GluA2 
subunits even in the absence of ADAR2. The ADAR2-deficient AHCs displayed normal Nup62 immunoreactiv-
ity in the AR2res mice at 3 and 9 months of age (Fig. 2a, arrows). Because TDP-43 was cleaved by calpain and 
exhibited mislocalization and motor neuron death was induced in a Ca2+-dependent manner in the ADAR2-
deficient motor neurons of AR2 mice21,22,27,28 (Supplementary Fig. S3), we compared the immunoreactivity to 
Nup62 and TDP-43 in motor neurons between the AR2 and AR2res mice. The numbers of AHCs positive for both 
Nup62 and TDP-43 were higher in the AR2res mice than in the AR2 mice, and virtually no motor neurons in the 
AR2res mice were negative for both Nup62 and TDP-43 (Fig. 2b). Moreover, the number of choline acetytras-
ferase (ChAT)-positive AHCs that were Nup62-positive was decreased in the AR2 mice compared to that in the 
wild type mice (Supplementary Fig. S3). These results indicate that activated calpain degraded and denatured the 
NPC via up-regulation of Ca2+-permeable AMPA receptors in motor neurons of AR2 mice in a manner depend-
ent on ADAR2 ablation.
Defective nucleo-cytoplasmic transport in ADAR2-deficient motor neurons. We next examined 
the changes in the subcellular localization of proteins associated with classical nuclear import and the impor-
tin recycling system. The cargo proteins karyopherin, importin, exportin, and transportin play important roles 
in nucleo-cytoplasmic transport, and the recycling of nucleo-cytoplasmic transporters is regulated by Ran 
GTPases such as RanGAP and RanBP129. We found that the subcellular localization of KPNA1 and KPNB1, 
members of the karyopherin protein family, was different between ADAR2-positive and ADAR2-deficient AHCs. 
ADAR2-positive AHCs in wild-type and AR2 mice exhibited KPNA1 immunoreactivity in the cytoplasm and 
KPNB1 immunoreactivity in the nucleus and the cytoplasm. Alternatively, ADAR2-deficient AHCs in AR2 mice 
were devoid of specific KPNA1 and KPNB1 immunoreactivity (Fig. 3a). Immunoreactivity for cellular apopto-
sis susceptibility protein (CAS), also known as exportin-2, was predominant in the nucleus of ADAR2-positive 
motor neurons but was faintly detected in the cytoplasm of ADAR2-deficient motor neurons. Immunoreactivity 
for RanBP1, which controls assembly/disassembly of certain karyopherin-cargo complexes30, was predominantly 
cytoplasmic in ADAR2-positive motor neurons but was nuclear or undetectable in ADAR2-deficient motor neu-
rons (Fig. 3b and Supplementary Fig. S4).
Because TDP-43 pathology in motor neurons is a pathological hallmark of ALS31,32 and because motor neu-
rons exhibiting TDP-43 pathology invariably lack ADAR2 immunoreactivity33, we next examined Nup62 and 
KPNB1 immunoreactivity in combination with ADAR2 or TDP-43 immunoreactivity in motor neurons of 
sporadic ALS patients. ADAR2-positive neurons, but not ADAR2-deficient neurons, showed normal ring-like 
Nup62 immunoreactivity in the perinuclear region, (Fig. 4a). AHCs with nuclear TDP-43 immunoreactiv-
ity exhibited normal perinuclear Nup62 immunoreactivity (Fig. 4b upper panels), whereas AHCs with TDP-
43-positive cytoplasmic inclusions exhibited Nup62 immunoreactivity along the tortuous nuclear membrane 
or no Nup62 immunoreactivity (Fig. 4b middle and lower panels). Similarly, in contrast to the round perinu-
clear KPNB1 immunoreactivity in motor neurons with nuclear TDP-43 (Fig. 4c upper panels), motor neurons 
with TDP-43-positive inclusions exhibited no KPNB1 immunoreactivity or irregular and discontinuous peri-
nuclear KPNB1 immunoreactivity (Fig. 4c lower panels). Moreover, the KPNA1 and KPNB1 immunostaining 
in the ADAR2-deficient AHCs of AR2res mice exhibited normal distribution (Supplementary Fig. S5). Because 
ADAR2-lacking AHCs in the AR2res mice express edited GluA2 and hence Ca2+-impermeable AMPA receptors, 
these results indicate that the NPC and the nucleo-cytoplasmic transport system are altered in ADAR2-deficient 
AHCs of sporadic ALS patients in a manner dependent on Ca2+ influx.
Altered gene expression in motor neurons with disrupted NPCs. The observation of tortuous 
ring-like Nup62 and KPNB1 immunoreactivity (Fig. 4) suggested that the nuclear membranes of ADAR2-deficient 
motor neurons in ALS patients were distorted. Members of the lamin protein family are nuclear envelope proteins 
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Figure 1. The NPC was degraded and denatured by calpain. (a,b) Representative immunofluorescence 
staining for ADAR2 and Nups in AHCs of a wild-type (a) and an AR2 mouse (b). Immunofluorescence assays 
showed that the Nups (green) were localized to the perinuclear region of ADAR2-postive AHCs but lacked 
detectable expression in ADAR2-negative AHCs of an AR2 mouse. Arrows indicate AHCs that appear in the 
magnified images. (c) Western blotting for Flag. Flag-Nup153, Flag-Nup88, and Flag-Nup62 were cleaved by 
recombinant calpain-I. (d) AHCs with high immunoreactivity for the 136 kDa fragment of alpha-spectrin 
(136 kf) in an AR2 mouse did not exhibit normal perinuclear Nup62 immunoreactivity (arrow). TO-PRO-3 is a 
cellular marker (blue). Scale bar, 20 μ m.
www.nature.com/scientificreports/
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that are crucial for not only maintaining nuclear structure but also regulating transcription by modulating chro-
matin organization34–36. Lamin B, but not lamin A/C, was expressed in the mouse brain and spinal cord (Fig. 5a), 
and lamin B was predominantly localized to the cytoplasm, particularly the perinuclear region, in motor neurons 
of wild-type mice (Fig. 5b,d). In contrast, lamin B expression was not detected in ADAR2-deficient AHCs of AR2 
mice (Fig. 5b,d). These AHCs devoid of both lamin B and ADAR2 expression exhibited 136kf expression in the 
nucleus (Fig. 5b,c,d,e and Supplementary Fig. S6).
Next, we tested whether these structural and functional changes in the nucleo-cytoplasmic transport system 
affected gene expression. The expression of RNA polymerase II phosphorylated at Ser2 (pol II Ser2), a transcript 
elongation enzyme, was markedly decreased in AHCs of AR2 mice (Fig. 5f ). In addition, the number 
of pol II Ser2-positive AHCs was significantly lower in AR2 mice than in wild-type mice (Fig. 5g and 
Supplementary Fig. S7). Moreover, these changes in AR2 mice were rescued in AR2res mice (Fig. 5f,g and 
Supplementary Fig. S7).
Figure 2. Rescue of Nup62 in AHCs of AR2res mouse. (a) Irrespective of ADAR2 expression (arrow), all 
AHCs in an AR2res mouse expressed Nup62 protein in the perinuclear region. TO-PRO-3 is a cellular staining 
marker. Scale bars, 20 μ m. (b) The numbers of AHCs that were notably immunoreactive for Nup62 and TDP-43  
in the AR2, AR2res and wild-type (WT) mice at different ages. The mean number of AHCs ± s.e.m. in a single 
anterior horn is indicated (n = 4–5, **P < 0.005 compared to the levels in wild-type or AR2 mice, Mann-Whitney 
U-test). +:  positive immunoreactivity; −:  negative immunoreactivity.
www.nature.com/scientificreports/
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Discussion
In this study, we showed that physiological nucleo-cytoplasmic transport was disrupted in dying ADAR2-deficient 
motor neurons via a Ca2+-permeable AMPA receptor-mediated mechanism in AR2 mice, a mechanistic mouse 
model of sporadic ALS. In this model, Nups, the components of the NPC, were cleaved by the Ca2+-dependent 
cysteine protease calpain, and immunoreactivity for Nups and cargo proteins involved in nucleo-cytoplasmic 
transport was markedly altered in ADAR2-deficient AHCs. Notably, analogous changes in the expression of 
Nups and importins were observed in the spinal AHCs of patients with ALS in a manner dependent on ADAR2 
down-regulation.
The NPC serves as a gateway for nucleo-cytoplasmic transport, and karyopherins (KPNA1 and KPNB1), CAS 
and RanBP1 are cargo proteins involved in nuclear import, nuclear export and recycling of nucleo-cytoplasmic 
transporters, respectively29. Export of RanBP1 from the nucleus to the cytoplasm depends on the chromosome 
region maintenance 1 (CRM1)-dependent nuclear export system30, and the down-regulation of RanBP1 resulted 
in the death of cultured cells37,38. Therefore, the finding of marked alteration of the subcellular localization of 
nucleo-cytoplasmic cargo proteins in this study suggests robust impairment of nuclear function due to cleavage 
of NPC components such as Nups by calpain in ADAR2-deficient AHCs.
Malfunction of nucleo-cytoplasmic transport caused by Ca2+ dysregulation has been proposed to occur in 
degenerative diseases39, and excess Ca2+ influx reportedly disrupts nucleo-cytoplasmic transport as a result of 
calpain-dependent degradation of NPC components10,40,41, including nuclear lamins and Nups. Disruption of the 
NPC enabled redistribution of calpains from the cytoplasm to the nucleus across the nuclear membrane during 
an acute excitotoxic insult10, but the pathogenic role of NPC disruption and the occurrence of NPC disruption 
during the slow neuronal death process have not been demonstrated. The present results indicated that activated 
calpain was localized to the nucleus, suggesting that nuclear dislocation of calpain occurred not only upon acute 
excitotoxic insult but also during a non-acute process of neuronal death. Ca2+ freely crosses nuclear membrane, 
and changes in the nucleoplasmic Ca2+ levels can directly regulate gene expression42. However, calpain becomes 
mislocalized in the nucleus only after disruption of nucleo-cytoplasmic transport. The loss of expression of the 
structural nuclear envelope protein lamin B in ADAR2-deficient AHCs of AR2 mice is likely due to its cleav-
age by mislocalized calpain. GLE1, the product of the recently identified ALS-associated gene GLE111, was also 
found to be cleaved by calpain1 in vitro (data not shown). Calpain-1 mislocalized to the nucleus cleaved his-
tone H3, thereby affecting gene expression to induce epithelial cell death during mammary gland differentia-
tion41. Disrupted nucleo-cytoplasmic transport of RNAs and RBPs including RanBP1 may accelerate cell death 
Figure 3. ADAR2 down-regulation causes nucleo-cytoplasmic transport defects in the motor neurons of AR2 
mice. Immunofluorescence staining for ADAR2 (red) and for proteins involved in nucleo-cytoplasmic transport 
(green) in mouse AHCs. (a) The ADAR2-deficient AHCs in an AR2 mouse (arrow) lacked normal nuclear 
KPNA1 and KPNB1 immunoreactivity. (b) The ADAR2-deficient AHCs lacked CAS immunoreactivity, and 
exhibited depleted RanBP1 immunoreactivity (arrow). TO-PRO-3 is a cellular marker (blue). Scale bar, 20 μ m.
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Figure 4. Nucleo-cytoplasmic transport defects in ADAR2-deficient motor neurons of sporadic ALS 
patients. (a) An ADAR2-positive AHC expressed Nup62 in the perinuclear region (arrow), whereas an ADAR2-
negative AHC lacked Nup62 protein expression (arrowhead). (b) A TDP-43-positive AHC in a sporadic ALS 
patient expressed the Nup62 protein in a round perinuclear region, whereas an AHC with cytoplasmic TDP-43 
inclusions exhibited distorted perinuclear Nup62 immunoreactivity and a TDP-43-negative AHC lacked Nup62 
protein expression. (c) A TDP-43-positive AHC expressed the KPNB1 protein in the perinuclear region and the 
nucleus, whereas AHCs with TDP-43 inclusions showed irregular and discontinuous nuclear KPNB1 protein 
immunoreactivity. Asterisks in all panels indicate autofluorescence of lipofuscin. Scale bars, 30 μ m.
www.nature.com/scientificreports/
7Scientific RepoRts | 7:39994 | DOI: 10.1038/srep39994
signaling, and down-regulation of pol II Ser2 as observed in this study likely reflects overall dysregulation of gene 
expression in dying motor neurons in AR2 mice.
Disrupted nucleo-cytoplasmic transport has recently attracted interest as a potential cause of ALS14–16,43 in 
association with the leading hypothesis of dysregulation of RNA metabolism2, but the mechanism underlying 
ALS pathology remains largely unresolved. In this study, we demonstrated that degeneration of the NPC in motor 
neurons of ALS patients was associated with ADAR2 down-regulation and TDP-43 pathology, which suggests the 
Figure 5. Nuclear dysfunction in motor neurons with NPC disruption. (a) Western blot showed that lamin 
B is the predominant member of the lamin family in the mouse brain and spinal cord. The lanes indicated 
(lane 1: brain, lane 2: spinal cord, lane 3: muscle, lane 4: liver). (b) Cytoplasmic and perinuclear lamin B 
immunoreactivity was detected in a wild-type mouse AHC but not in an AR2 mouse AHC. Scale bar, 20 μ m.  
(c) Immunoreactivity for 136kf was observed in AR2 mouse AHCs deficient lamin B expression. Scale bar, 20 μ m. 
(d) The number of lamin B-positive AHCs. Means (columns) and s.e.m. (bars) are indicated (The number of 
total AHCs; n = 5; *P = 0.0119 compared to the wild-type levels. The number of lamin B-negative AHCs; n = 12; 
***P < 0.001 compared to the wild-type levels, Student’s t-test). (e) The proportion of AHCs positive for 136 kf 
among all AHCs in AR2 mice and wild-type mice, both at 28 weeks of age. Means (columns) and s.e.m. (bars) 
are indicated (n = 4; *P = 0.0284 compared to the wild-type levels, Student’s t-test). (f,g) The proportion of 
AHCs positive for pol II Ser2 (green) among the AHCs in AR2, wild-type or AR2res mice (28 weeks of age). 
Significantly fewer pol II Ser2-positive neurons were detected in AR2 mice than in wild-type and AR2res mice. 
TO-PRO-3 is a cellular marker (blue). Means (columns) and s.e.m. (bars) are indicated (n = 5; *P = 0.0105 and 
**P < 0.001 compared to the wild-type or AR2res levels, Student’s t-test).
www.nature.com/scientificreports/
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presence of an underlying calpain-dependent mechanism, as noted in AR2 mice. Progressive down-regulation 
of ADAR2 is a characteristic feature of motor neurons in sporadic ALS patients25, which leads to dysregulation 
of RNA metabolism due to failure of the A-to-I conversion in pre-mRNA. The crucial function of ADAR2 is 
RNA editing at the GluA2 Q/R site, but the main mediators of the downstream events leading to cell death are 
Ca2+ influx and activity of calpains, which degrade physiologically functioning molecules, including TDP-43 
and Nups, rather than failure of the A-to-I conversion in RNAs20,21. Interestingly, present results suggest that 
dysregulation of RNA metabolism by ADAR2 down-regulation indirectly affects gene expression via altering 
physiologically crucial protein functions.
ADAR2-deficient motor neurons in both AR2 mice and sporadic ALS patients share several characteristics, 
including slow progressive death of motor neurons except for those innervating extraocular muscles, expression 
of Q/R site-unedited GluA2, and mislocalization of TDP-4317–21,33. Here, we observed calpain-dependent deg-
radation of Nups and nucleo-cytoplasmic transport elements in dying motor neurons as an additional common 
feature between AR2 mice and those of sporadic ALS patients. The multifaceted pathological similarities between 
sporadic ALS patients and AR2 mice lend further support to the hypothesis that ADAR2 down-regulation plays 
a pivotal role in ALS pathogenesis. The present results suggest that the role of disruption of nucleo-cytoplasmic 
transport and the resultant dysregulation of gene expression in calpain-mediated cell death44,45 is involved in the 
mechanism underlying the death of motor neurons in ALS patients. Future studies will be required to elucidate 
the molecular cascade whereby disrupted nucleo-cytoplasmic transport causes cell death, which could aid in the 
development of novel mechanism-based therapies for FTD/ALS.
Methods
Antibodies. The following primary antibodies were used: rabbit anti-FLAG (Cell Signaling Technology); 
mouse anti-nucleoporin p62 (BD Transduction Labs); mouse anti-human Nup88 (BD Transduction Labs); mouse 
anti-Nup153 (QE5, Abcam); rabbit anti-136kf (specific calpain-dependent cleavage fragment of alpha-spectrin, a 
gift from Dr. T.C. Saido, Laboratory for Proteolytic Neuroscience, RIKEN Brain Science Institute24); rabbit anti-
RNA polymerase II CTD repeat YSPTSPS (phospho-S2) (Abcam); mouse anti-RNA polymerase II H5 (Covance); 
goat anti-lamin B (Santa Cruz Biotechnologies, Inc.); mouse anti-lamin A/C (Santa Cruz Biotechnologies, Inc.); 
rabbit anti-nucleoporin p62 (Abcam); rabbit anti-Nup88 (Abcam); rabbit anti-human beta-actin (IMGENEX 
Corp.); sheep anti-rat RED1 (ADAR2, Exalpha Biologicals, Inc.); rabbit anti-ADARB1 (ADAR2, Sigma Aldrich); 
rabbit anti-KPNA3 (Abcam); rabbit anti-KPNA1/SRP1 (Abcam); rabbit anti-CAS (Abcam); mouse anti-transpor-
tin 1 (Abcam); rabbit anti-CRM1 (Santa Cruz Biotechnologies, Inc.); rabbit anti-karyopherin beta 3 (Santa Cruz 
Biotechnologies, Inc.); rabbit anti-karyopherin beta 1 (Santa Cruz Biotechnologies, Inc.); rabbit anti-KPNA2 
(Abcam); and rabbit anti-RanBP1 (Novus Biotech, Inc., Littleton, CO, USA); goat anti-ChAT (Milllipore).
The following secondary antibodies were used for immunohistochemistry: Alexa Fluor 488 donkey anti-sheep 
IgG, Alexa Fluor 488 goat anti-mouse IgG, Alexa Fluor 488 donkey anti-goat IgG, Alexa Fluor 647 chicken 
anti-rabbit IgG, Alexa Fluor 647 chicken anti-mouse IgG (Invitrogen). Peroxidase-conjugated goat anti-rabbit 
IgG and peroxidase-conjugated horse anti-mouse IgG (Cell Signaling Technology, Inc., Danvers, MA, USA) were 
the secondary antibodies used for immunoblot analyses.
Construction of plasmids. To generate full-length human Nup62, Nup88 and Nup153 expression constructs, 
we first amplified the Nup62, Nup88 and Nup153 coding regions from cDNA generated from human spinal cord 
RNA using the following primers: hNUP62-XhoIup1 (5′ -AAAAACTCGAGATGAGCGGGTTTAAT 
TTTGGAGGCACTG-3′ ) and hNUP62-SalIdown1 (5′ -AAAAAGTCGACTCAGTCAAAGGTGATCC 
GGAAGCTGCGCTC-3′ ); hNUP88-KpnIup1 (5′ -AAAAAGGTACCATGGCGGCCGCCGAGGGAC 
CGGTGGGCGAC-3′ ) and hNUP88-SalIdown1 (5′ -AAAAAGTCGACTCAGAAGTTTACATGATTGCGG 
ATATCATTG-3′ ); or hNUP153-KpnIup1 (5′ -AAAAAGGTACCATGGCCTCGGGAGCCGGAGGAGTCG 
GAG-3′ ) and hNUP153-SalIdown1 (5′ -AAAAAGTCGACTTATTTCCTGCGTCTAACAGCAGTCTTTATC-3′ ). 
After gel purification, the PCR products were digested with SalI and either XhoI or KpnI, and the appropriate 
fragments were cloned into a pCI mammalian expression vector (Promega) that was digested with the same 
restriction enzymes. Flag-tagged full-length Nup62, Nup88 and Nup153 constructs were generated using a KOD 
Plus mutagenesis kit (TOYOBO). All constructs were verified by DNA sequencing.
Cell culture and transfection. HeLa cells were cultured in MEM-alpha medium (WAKO, Tokyo, Japan) sup-
plemented with 10% fetal bovine serum (Invitrogen, Carlsbad, CA, USA), 100 U/ml penicillin and 100 μ g/ml strep-
tomycin (Invitrogen) in 5% CO2 at 37 °C. The cells were seeded in 6-well plates at a density of 3.5 × 104 cells/cm2. 
The HeLa cells were transfected with 2.5 μ g of an expression plasmid using Lipofectamine 3000 transfection rea-
gent (Invitrogen). The cells were cultured for 72 hours after transfection and were then harvested.
In vitro calpain and caspase assays. HeLa cells were homogenised by sonication in 10 volumes of extrac-
tion buffer (50 mM HEPES, pH 7.5, 1 mM EDTA, 100 mM NaCl, 10 mM DTT and 0.1% CHAPS). The homogen-
ate was centrifuged at 1,000 g for 10 min at 4 °C. The supernatant was incubated at 30 °C with 3.0 units of purified 
human erythrocyte μ -calpain (calpain-I) in extraction buffer with 5 mM CaCl2. The reaction was stopped by 
addition of SDS sample buffer containing 62.5 mM Tris-HCl, pH 6.8, 4% SDS, 10% glycerol, 50 mM DTT, and 
0.1% bromophenol blue. The samples were boiled at 100 °C for 5 min.
Animals. The mutant animals used in this study were homozygous (ADAR2flox/flox/VAChT-Cre.Fast) condi-
tional ADAR2 knockout (AR2) mice. In AR2 mice, the ADAR2 gene is conditionally ablated in motor neurons 
using VAChT promoter-driven Cre in the Cre/loxP system20. AR2res (ADAR2flox/flox/VAChT-Cre.Fast/GluR-BR/R) 
mice were generated by crossing AR2 mice with GluR-BR/R mice, in which the endogenous GluA2 gene was engi-
neered to encode directly edited GluA2. In the AR2res mice, ADAR2-deficient motor neurons did not undergo 
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neuronal death by 6 months of age20. Both genders of AR2 and AR2res mice were used in this study. C57BL/6 J 
mice (Oriental Yeast Co., Ltd.) of the same age were used as the WT control of the same strain. In this study, 
homozygous AR2 mice at 12, 26, 28, 36, 38 weeks of age and AR2res mice at 12, 28, 36 weeks of age and wild type 
mice at 26, 28, 36 weeks of age were used for all experiments. The mice were housed at two to three per cage on a 
12 h: 12 h light-dark cycle with free access to food and water. All of the studies were approved by the Committee 
on Animal Handling at the University of Tokyo and were performed in accordance with the guidelines for animal 
experiments of the Ministry of Education, Culture, Sports, Science and Technology, Japan.
Human material and preparation of samples. Human spinal cord specimens were fixed in 10% neutral 
buffered formalin for approximately 7 days and then embedded in paraffin. Serial 7-μ m sections were sliced. The 
sections were mounted on slides, deparaffinized in xylene, hydrated with a graded ethanol series and heated at 
120 °C for 2 min for antigen retrieval. The sections were then washed with phosphate-buffered saline (PBS) and 
incubated with a primary antibody overnight at 4 °C. Written informed consent for autopsy and approval for 
the use of autopsy tissue specimens for research purposes was obtained before death from all subjects, and the 
research project has been approved by the Institutional Human Ethics Committees of Tokyo Medical University. 
All methods were performed in accordance with the relevant guidelines and regulations by including a statement 
in the methods section to this effect.
Protein extraction. The samples, including frozen mouse muscles, livers, brains and spinal cords, were 
homogenized in 10 volumes of extraction buffer (5 mM cysteine and 150 mM imidazole, pH 7.5) containing a 
protease inhibitor cocktail supplemented with 5 mM ethylenediaminetetraacetic acid (EDTA) (Pierce). After the 
homogenate was centrifuged at 1,000 × g for 10 min at 4 °C, SDS sample buffer (62.5 mM Tris-HCl, pH 6.8, 4% 
SDS, 10% glycerol, 50 mM DTT, and 0.1% bromophenol blue) was added, and the sample was boiled at 100 °C for 
5 min immediately prior to SDS-PAGE analysis.
Western blot analysis. Each sample was subjected to 7.5%, 12.5% or 15% (v/v) SDS-PAGE using a 
Tris-glycine buffer system, and the separated proteins were transferred to polyvinylidene difluoride membranes 
(Millipore). The membranes were blocked with 3% (v/v) skim milk and 1% (v/v) bovine serum albumin (BSA) in 
PBS containing 0.1% (w/v) Tween-20 for 3 hours, followed by incubation at 4 °C overnight with the indicated pri-
mary antibody at an appropriate dilution (1:2,000) in PBS containing 3% (v/v) skim milk, 1% (v/v) BSA, and 0.1% 
(w/v) Tween-20. The membranes were washed and then incubated with a horseradish peroxidase-conjugated sec-
ondary antibody (1:2,000) (Cell Signaling Technology, Inc., Danvers, MA, USA) at room temperature for 1 hour. 
Signals were detected using Pierce Western Blotting Substrate Plus (Thermo Scientific, Southfield, MI, USA). The 
intensities of specific bands were quantitatively measured using an LAS-3000 mini imaging system (FujiFilm Co., 
Tokyo, Japan) equipped with Multi-Gauge Ver3.0 software (FujiFilm). As an internal control, the expression of 
β -actin was measured.
Immunofluorescence analysis. Under deep anesthesia with isoflurane, mice were transcardially perfused 
with 3.5% paraformaldehyde and 0.5% glutaraldehyde in PBS. The spinal cords were removed and immersed in 
serially increasing concentrations of sucrose in PBS (final sucrose concentration of 30%). The sucrose-immersed 
spinal cord specimens were sliced to a thickness of 10 μ m using a cryostat (Model LEICA CM1850; LEICA). 
The sections were blocked with 10% (v/v) skim milk in PBS. Immunofluorescence staining of the sections was 
performed using the indicated primary antibodies. The sections were then incubated with Alexa Fluor 488 
(Invitrogen, 1:200) and Alexa Fluor 647 secondary antibodies (Invitrogen, 1:200). The sections were examined 
under a fluorescence microscope (BIOREVO BZ-9000; Keyence Corp, Osaka, Japan) after staining the cells with 
0.5 μ M TO-PRO-3 for 60 min.
Morphological observation. Sections of the fifth lumbar (L5) spinal cord segment were sequentially immu-
nostained with several antibodies using an immunofluorescence system. The fluorescent images were analyzed 
using a fluorescence microscope (BIOREVO BZ-9000; Keyence Corp, Osaka, Japan). Target antigen-positive and 
-negative motor neurons with diameters larger than 20 μ m by TO-PRO-3 staining were separately counted in 
four sections per mouse. In this study, TO-PRO-3 was used as a cell marker throughout our experiments28,46,47. In 
addition, to analyze motor neurons more selectivity, ChAT-positive AHCs were counted in five sections immu-
nostained using goat anti-ChAT polyclonal antibody (Milllipore Cat. No. AB144P) for each mouse. The number 
of AHCs in the ventral gray matter (ventral to the horizontal line running though the ventral edge of the central 
canal) was counted in five L5 sections for each mouse.
Statistical analysis. Averaged data are presented as means and s.e.m. Statistical analysis was performed 
using JMP 12 software (SAS Institute, Inc.). For statistical comparisons of two groups, we used unpaired 
two-tailed Student’s t-tests. Differences were considered significant when P < 0.05.
References
1. Davidson, T. J. & Hartmann, H. A. RNA content and volume of motor neurons in amyotrophic lateral sclerosis. II. The lumbar 
intumescence and nucleus dorsalis. J Neuropathol Exp Neurol. 40, 187–192 (1981).
2. Paez-Colasante, X., Figueroa-Romero, C., Sakowski, S. A., Goutman, S. A. & Feldman, E. L. Amyotrophic lateral sclerosis: 
mechanisms and therapeutics in the epigenomic era. Nat Rev Neurol. 11, 266–279 (2015).
3. Ling, S. C., Polymenidou, M. & Cleveland, D. W. Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis. 
Neuron 79, 416–438 (2013).
4. Walsh, M. J. et al. Invited review: decoding the pathophysiological mechanisms that underlie RNA dysregulation in 
neurodegenerative disorders: a review of the current state of the art. Neuropathol Appl Neurobiol. 41, 109–134 (2015).
5. Bilokapic, S. & Schwartz, T. U. 3D ultrastructure of the nuclear pore complex. Current Opinion in Cell Biology 24, 86–91 (2012).
www.nature.com/scientificreports/
1 0Scientific RepoRts | 7:39994 | DOI: 10.1038/srep39994
6. Delaleau, M. & Borden, K. L. Multiple Export Mechanisms for mRNAs. Cells 4, 452–473 (2015).
7. Kihlmark, M., Imreh, G. & Hallberg, E. Sequential degradation of proteins from the nuclear envelope during apoptosis. Journal of 
cell science 114, 3643–3653 (2001).
8. Nousiainen, H. O. et al. Mutations in mRNA export mediator GLE1 result in a fetal motoneuron disease. Nat Genet. 40, 155–157 
(2008).
9. Folkmann, A. W. et al. Gle1 functions during mRNA export in an oligomeric complex that is altered in human disease. Cell 155, 
582–593 (2013).
10. Bano, D. et al. Alteration of the nuclear pore complex in Ca(2+ )-mediated cell death. Cell Death Differ. 17, 119–133 (2010).
11. Kaneb, H. M. et al. Deleterious mutations in the essential mRNA metabolism factor, hGle1, in amyotrophic lateral sclerosis. Hum 
Mol Genet. 24, 1363–1373 (2015).
12. Nagara, Y. et al. Impaired cytoplasmic-nuclear transport of hypoxia-inducible factor-1alpha in amyotrophic lateral sclerosis. Brain 
Pathol. 23, 534–546 (2013).
13. Kinoshita, Y. et al. Nuclear contour irregularity and abnormal transporter protein distribution in anterior horn cells in amyotrophic 
lateral sclerosis. J Neuropathol Exp Neurol. 68, 1184–1192 (2009).
14. Jovicic, A. et al. Modifiers of C9orf72 dipeptide repeat toxicity connect nucleocytoplasmic transport defects to FTD/ALS. Nat 
Neurosci. 18, 1226–1229 (2015).
15. Freibaum, B. D. et al. GGGGCC repeat expansion in C9orf72 compromises nucleocytoplasmic transport. Nature (2015).
16. Zhang, K. et al. The C9orf72 repeat expansion disrupts nucleocytoplasmic transport. Nature (2015).
17. Hideyama, T. et al. Profound downregulation of the RNA editing enzyme ADAR2 in ALS spinal motor neurons. Neurobiol Dis. 45, 
1121–1128 (2012).
18. Takuma, H., Kwak, S., Yoshizawa, T. & Kanazawa, I. Reduction of GluR2 RNA editing, a molecular change that increases calcium 
influx through AMPA receptors, selective in the spinal ventral gray of patients with amyotrophic lateral sclerosis. Ann Neurol. 46, 
806–815 (1999).
19. Kawahara, Y. et al. Glutamate receptors: RNA editing and death of motor neurons. Nature 427, 801 (2004).
20. Hideyama, T. et al. Induced loss of ADAR2 engenders slow death of motor neurons from Q/R site-unedited GluR2. J Neurosci. 30, 
11917–11925 (2010).
21. Yamashita, T. et al. A role for calpain-dependent cleavage of TDP-43 in amyotrophic lateral sclerosis pathology. Nat Commun. 3, 
1307 (2012).
22. Yamashita, T. & Kwak, S. The molecular link between inefficient GluA2 Q/R site-RNA editing and TDP-43 pathology in motor 
neurons of sporadic amyotrophic lateral sclerosis patients. Brain Res. 1584, 28–38 (2014).
23. Sasaki, S., Yamashita, T., Hideyama, T. & Kwak, S. Unique nuclear vacuoles in the motor neurons of conditional ADAR2-knockout 
mice. Brain Res. 1550, 36–46 (2014).
24. Higuchi, M. et al. Mechanistic involvement of the calpain-calpastatin system in Alzheimer neuropathology. FASEB J. 26, 1204–1217 
(2012).
25. Hideyama, T. & Kwak, S. When Does ALS Start? ADAR2-GluA2 Hypothesis for the Etiology of Sporadic ALS. Frontiers in molecular 
neuroscience 4, 33 (2011).
26. Kask, K. et al. The AMPA receptor subunit GluR-B in its Q/R site-unedited form is not essential for brain development and function. 
Proc Natl Acad Sci USA 95, 13777–13782 (1998).
27. Yamashita, T. et al. Rescue of amyotrophic lateral sclerosis phenotype in a mouse model by intravenous AAV9-ADAR2 delivery to 
motor neurons. EMBO Mol Med. 5, 1710–1719 (2013).
28. Akamatsu, M., Yamashita, T., Hirose, N., Teramoto, S. & Kwak, S. The AMPA receptor antagonist perampanel robustly rescues 
amyotrophic lateral sclerosis (ALS) pathology in sporadic ALS model mice. Scientific reports 6, 28649 (2016).
29. Miyamoto, Y., Boag, P. R., Hime, G. R. & Loveland, K. L. Regulated nucleocytoplasmic transport during gametogenesis. Biochimica 
et Biophysica Acta. 1819, 616–630 (2012).
30. Niu, M., Chong, Y., Han, Y. & Liu, X. Novel reversible selective inhibitor of nuclear export shows that CRM1 is a target in colorectal 
cancer cells. Cancer biology & therapy 16, 1110–1118 (2015).
31. Arai, T. et al. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and 
amyotrophic lateral sclerosis. Biochem Biophys Res Commun. 351, 602–611 (2006).
32. Neumann, M. et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science (New 
York, NY). 314, 130–133 (2006).
33. Aizawa, H. et al. TDP-43 pathology in sporadic ALS occurs in motor neurons lacking the RNA editing enzyme ADAR2. Acta 
Neuropathol. 120, 75–84 (2010).
34. Shimi, T. et al. The A- and B-type nuclear lamin networks: microdomains involved in chromatin organization and transcription. 
Genes and Development 22, 3409–3421 (2008).
35. Shimi, T., Butin-Israeli, V. & Goldman, R. D. The functions of the nuclear envelope in mediating the molecular crosstalk between the 
nucleus and the cytoplasm. Current Opinion in Cell Biology 24, 71–78 (2012).
36. Freund, A., Laberge, R. M., Demaria, M. & Campisi, J. Lamin B1 loss is a senescence-associated biomarker. Molecular Biology of the 
Cell 23, 2066–2075 (2012).
37. Li, H. Y., Ng, W. P., Wong, C. H., Iglesias, P. A. & Zheng, Y. Coordination of chromosome alignment and mitotic progression by the 
chromosome-based Ran signal. Cell cycle (Georgetown, Tex) 6, 1886–1895 (2007).
38. Tedeschi, A. et al. RANBP1 localizes a subset of mitotic regulatory factors on spindle microtubules and regulates chromosome 
segregation in human cells. Journal of cell science 120, 3748–3761 (2007).
39. Mattson, M. P. et al. Calcium signaling in the ER: its role in neuronal plasticity and neurodegenerative disorders. Trends Neurosci. 
23, 222–229 (2000).
40. Arnandis, T. et al. Differential functions of calpain 1 during epithelial cell death and adipocyte differentiation in mammary gland 
involution. Biochemical Journal 459, 355–368 (2014).
41. Santella, L. et al. Breakdown of cytoskeletal proteins during meiosis of starfish oocytes and proteolysis induced by calpain. 
Experimental cell research 259, 117–126 (2000).
42. Alonso, M. T. & Garcia-Sancho, J. Nuclear Ca(2+ ) signalling. Cell Calcium 49, 280–289 (2011).
43. Stalekar, M. et al. Proteomic analyses reveal that loss of TDP-43 affects RNA processing and intracellular transport. Neuroscience 
293, 157–170 (2015).
44. Cronshaw, J. M. & Matunis, M. J. The nuclear pore complex: disease associations and functional correlations. Trends Endocrinol 
Metab. 15, 34–39 (2004).
45. Gijselinck, I. et al. The C9orf72 repeat size correlates with onset age of disease, DNA methylation and transcriptional downregulation 
of the promoter. Molecular Psychiatry (2015).
46. Hideyama, T., Teramoto, S., Hachiga, K., Yamashita, T. & Kwak, S. Co-Occurrence of TDP-43 Mislocalization with Reduced Activity 
of an RNA Editing Enzyme, ADAR2, in Aged Mouse Motor Neurons. PLoS One 7, e43469 (2012).
47. Shao, C. Y., Mirra, S. S., Sait, H. B., Sacktor, T. C. & Sigurdsson, E. M. Postsynaptic degeneration as revealed by PSD-95 reduction 
occurs after advanced Abeta and tau pathology in transgenic mouse models of Alzheimer’s disease. Acta Neuropathol. 122, 285–292 
(2011).
www.nature.com/scientificreports/
1 1Scientific RepoRts | 7:39994 | DOI: 10.1038/srep39994
Acknowledgements
We thank Dr. Takaomi C. Saido (Laboratory for Proteolytic Neuroscience, RIKEN Brain Science Institute) 
for gifting the rabbit anti-136 kDa fragment of alpha-spectrin antibody and Prof. Kazunori Kataoka (Univ. of 
Tokyo) for kindly providing us with research facilities. This study was supported in part by Grants-in-Aid for 
Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan to T.Y. 
(25461269) and S.K. (22390173), and was sponsored by the ALS Foundation, the Japan ALS Association, and The 
Nakabayashi Trust For ALS Research, Tokyo, Japan.
Author Contributions
S.K. supervised the entire project. T.Y. and S.K. conceived and designed the experiments. T.Y. and S.K. wrote 
the main text, and T.Y. and H.A. produced the figures. T.Y., H.A., M.A. and S.T. performed the experiments and 
analyzed the data. All of the co-authors discussed the results and commented on the manuscript.
Additional Information
Supplementary information accompanies this paper at http://www.nature.com/srep
Competing financial interests: The authors declare no competing financial interests.
How to cite this article: Yamashita, T. et al. Calpain-dependent disruption of nucleo-cytoplasmic transport in 
ALS motor neurons. Sci. Rep. 7, 39994; doi: 10.1038/srep39994 (2017).
Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and 
institutional affiliations.
This work is licensed under a Creative Commons Attribution 4.0 International License. The images 
or other third party material in this article are included in the article’s Creative Commons license, 
unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, 
users will need to obtain permission from the license holder to reproduce the material. To view a copy of this 
license, visit http://creativecommons.org/licenses/by/4.0/
 
© The Author(s) 2017
